Pain
From the Journals
Possible mortality risk seen with tramadol in osteoarthritis
Older patients taking tramadol for osteoarthritis had significantly higher mortality risk than did patients taking NSAIDs.
Applied Evidence
Juvenile idiopathic arthritis: Old disease, new tactics
Beyond NSAIDs and disease-modifying antirheumatic drugs are now biologic agents and anti-interleukin drugs that can augment therapy.
Clinical Inquiries
Is intra-articular platelet-rich plasma injection an effective treatment for knee OA?
EVIDENCE-BASED ANSWER: Probably not, based on the balance of evidence. While low-quality evidence may suggest potential benefit,...
Applied Evidence
A systematic approach to chronic abnormal uterine bleeding
The care you provide to women of childbearing age who are bleeding gets an assist from an established classification system of 9 causes and a...
Conference Coverage
Migraine associated with more severe disability in patients with MS
DALLAS – “Traditional migraine risk factors such as obesity, anxiety, and depression were also overrepresented in our cohort” of patients with MS...
From the Journals
In California, opioids most often prescribed in low-income, mostly white areas
Opioid-related overdose deaths are highest in low-income white areas.
From the Journals
Cloud of inconsistency hangs over cannabis data
Number of medical cannabis users is up more than 10-fold since 2009, available data show.
Feature
Psoriatic arthritis eludes early diagnosis
Patients with psoriasis have an increased risk for psoriatic arthritis, but diagnosing its onset early poses challenges.
From the Journals
Compounded pain creams no better than placebo creams in localized chronic pain
At 1 month, creams specifically formulated for neuropathic, nociceptive, or mixed pain had no effect beyond placebo.
Conference Coverage
Expert: There’s no single treatment for fibromyalgia
SAN DIEGO – Physical activity is crucial, but it’s not enough on its own.
Applied Evidence
Migraine: Expanding our Tx arsenal
Beyond tried-and-true therapies are new therapeutic targets on the horizon—giving you a bigger toolbox to help patients abort and prevent migraine...